Cargando…

A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype

Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell prolife...

Descripción completa

Detalles Bibliográficos
Autores principales: Aly, Haytham, Rohatgi, Nidhi, Marshall, Connie A., Grossenheider, Tiffani C., Miyoshi, Hiroyuki, Stappenbeck, Thaddeus S., Matkovich, Scot J., McDaniel, Michael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680388/
https://www.ncbi.nlm.nih.gov/pubmed/23776620
http://dx.doi.org/10.1371/journal.pone.0066131
_version_ 1782273112512921600
author Aly, Haytham
Rohatgi, Nidhi
Marshall, Connie A.
Grossenheider, Tiffani C.
Miyoshi, Hiroyuki
Stappenbeck, Thaddeus S.
Matkovich, Scot J.
McDaniel, Michael L.
author_facet Aly, Haytham
Rohatgi, Nidhi
Marshall, Connie A.
Grossenheider, Tiffani C.
Miyoshi, Hiroyuki
Stappenbeck, Thaddeus S.
Matkovich, Scot J.
McDaniel, Michael L.
author_sort Aly, Haytham
collection PubMed
description Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human β-cell proliferation while maintaining a β-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis ∼6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human β-cell proliferation ∼20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced β-catenin-mediated and β-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype.
format Online
Article
Text
id pubmed-3680388
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36803882013-06-17 A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype Aly, Haytham Rohatgi, Nidhi Marshall, Connie A. Grossenheider, Tiffani C. Miyoshi, Hiroyuki Stappenbeck, Thaddeus S. Matkovich, Scot J. McDaniel, Michael L. PLoS One Research Article Our previous studies demonstrated that Wnt/GSK-3/β-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human β-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases β-catenin nuclear translocation and β-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human β-cell proliferation while maintaining a β-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis ∼6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human β-cell proliferation ∼20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced β-catenin-mediated and β-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/β-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human β-cell proliferation while maintaining the β-cell phenotype. Public Library of Science 2013-06-12 /pmc/articles/PMC3680388/ /pubmed/23776620 http://dx.doi.org/10.1371/journal.pone.0066131 Text en © 2013 Aly et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Aly, Haytham
Rohatgi, Nidhi
Marshall, Connie A.
Grossenheider, Tiffani C.
Miyoshi, Hiroyuki
Stappenbeck, Thaddeus S.
Matkovich, Scot J.
McDaniel, Michael L.
A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype
title A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype
title_full A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype
title_fullStr A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype
title_full_unstemmed A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype
title_short A Novel Strategy to Increase the Proliferative Potential of Adult Human β-Cells While Maintaining Their Differentiated Phenotype
title_sort novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680388/
https://www.ncbi.nlm.nih.gov/pubmed/23776620
http://dx.doi.org/10.1371/journal.pone.0066131
work_keys_str_mv AT alyhaytham anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT rohatginidhi anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT marshallconniea anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT grossenheidertiffanic anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT miyoshihiroyuki anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT stappenbeckthaddeuss anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT matkovichscotj anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT mcdanielmichaell anovelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT alyhaytham novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT rohatginidhi novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT marshallconniea novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT grossenheidertiffanic novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT miyoshihiroyuki novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT stappenbeckthaddeuss novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT matkovichscotj novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype
AT mcdanielmichaell novelstrategytoincreasetheproliferativepotentialofadulthumanbcellswhilemaintainingtheirdifferentiatedphenotype